Breast Augmentation (Implants) | Questions About Unusual Situations and Special Cases

A detailed surgical history matters, especially procedures involving the breast or donor sites. Revision breast surgery is broad and may address healing, infection, shape, symmetry or scars after earlier surgery. Implants can sit behind breast tissue, behind the chest muscle or under the fascia; incisions may be around the areola, in the breast fold or near the armpit. Silicone and saline implants differ; silicone gel may be used for secondary procedures in certain circumstances. Fat transfer may suit only a few people and often needs more than one operation; it can also be combined with implants. Breast augmentation does not correct severe drooping, so a lift may be needed at the same time or separately.

Breast reduction removes skin and tissue and reshapes the breast, so later augmentation is not simply reversing that change. Breast augmentation may use implants or fat transfer; implants can be saline or silicone and placed in different positions, while fat transfer suits selected patients with stable weight and suitable donor fat. Because reduction can leave asymmetry and cannot guarantee a specific size, adding volume later requires careful planning with your surgeon. Implant choice, pocket position and scar considerations should be discussed individually. Your remaining tissue, skin quality and goals also matter. A thorough examination helps set realistic expectations. The result you hope for cannot be guaranteed, and major surgery carries potential risks.

Pectus excavatum can tilt the breast inward and make nipples point medially; rotating the breast laterally can correct that appearance. Pectus carinatum tends to push breasts outward, so implants may slide toward the armpit. Minor deformities may be minimized by adding breast volume or rearranging tissue, while more significant ones may need custom prostheses or flap reconstruction. Bony reconstruction is usually not indicated without heart-lung problems, except in severe pectus carinatum. In pectus excavatum with small breasts, simultaneous pectus bar correction and augmentation may be useful, though supporting evidence is retrospective and small. Subpectoral dissection should be undertaken with great care because muscles may be poorly developed.

Pectus excavatum is the most common chest wall deformity and may be associated with underdeveloped breasts. In one small series of 11 healthy women aged 21-39, wide silicone implants were placed under the pectoralis major muscle; no acute or late augmentation-related complications occurred, all were satisfied, and none wanted further pectus surgery, although two had a small upper-breast depression from insufficient implant coverage. Other reports describe simultaneous pectus bar correction with subpectoral augmentation as useful in carefully selected patients. Implant position matters: prepectoral placement may better camouflage the deformity, while retropectoral placement can reduce projection and textured implants may cause late seroma from friction over time with individualized implant choice and careful preoperative planning.

Poland syndrome varies widely. It may involve a small breast, abnormal nipple-areola development, missing chest muscle, shoulder muscle thinning or hand differences. Surgery aims to create a breast mound, restore the underarm fold and replace missing fullness below the collarbone. The plan depends on severity and chest shape; mild to moderate volume loss may need fat transfer alone, while significant chest-wall deformity can affect augmentation and may need correction first. Implants, fat transfer, tissue expansion, flaps or combined reconstruction may be considered depending on the underlying breast and chest-wall deformity and patient preference. Each case needs individualized assessment and shared decision-making; breast augmentation alone may help some hypoplasia, but nipple-areola differences and chest-wall shape also matter.

Thin tissue cannot be changed by surgery, so implant selection should be tissue-based rather than based only on desired size. Very thin skin may not suit some implant planes, and thin patients with little fat can show implant contours or rippling; fat grafting may add soft-tissue cover in selected revision cases. Wide breasts with stretchy skin may need more volume to fill the upper breast, yet that same stretch can worsen thinning. Implant placement behind breast tissue, muscle or fascia depends on each patient, and incision options vary by breast characteristics. Skin quality should also guide implant choice to avoid overprojection, excessive stretching, tissue thinning and parenchymal atrophy.

A wide gap is not automatically a reason to avoid surgery, but routine augmentation does not relocate the breast on the torso. The gap is usually kept similar to reduce risks such as visible implant edges or traction rippling in the cleavage, which may be difficult to correct. In thin women with little fat and submuscular implants, separation can become more noticeable. Chest-wall shape, tuberosity or asymmetry may also need attention, and severe drooping may require a lift. Implants can be placed behind breast tissue, muscle or fascia, with incision choice based on your anatomy. Fat transfer offers subtle volume and may need more than one procedure.

Most women have some breast asymmetry. When one breast is smaller, augmentation may use different implant sizes or profiles; mild-to-moderate differences under about 90–120 cc may suit bilateral asymmetric implants. Significant asymmetry, drooping, or chest-wall differences can need additional procedures, and changing one breast may reveal another asymmetry. Breast size and other asymmetries are interdependent, so planning should consider all asymmetries. Correction is rarely perfect because different breasts heal differently and may need further surgery. A carefully prepared surgical plan and realistic goals improve positive outcomes; at least two unrushed comprehensive consultations are recommended. Implant selection should be tissue-based, considering width, height, envelope characteristics and limitations.

Keloids are scars that grow beyond the original wound and may persist; hypertrophic scars stay within wound boundaries. Keloids can occur with any surgical wound and may have a genetic tendency. They rarely regress. Patients with a history of keloid or hypertrophic scar formation may need steroid injected at the incision site around surgery. Breast augmentation incisions may be placed around the areola, in the inframammary fold, or at the axillary level depending on breast characteristics and surgeon or patient preferences. Keloids and hypertrophic scars can be treated with intralesional corticosteroids alone or combined with surgery, radiation, laser, cryotherapy, pressure therapy or silicone sheeting. Careful layered closure is key to reducing scar problems.

After massive weight loss, breasts may show excess skin, drooping, smaller or larger volume, and asymmetry. Augmentation can increase size and projection, but it does not correct severe drooping; a lift raises the nipple-areola complex and removes redundant skin. Fat transfer needs stable weight and suitable donor fat, while implants offer another option. Combined surgery may be considered when volume and skin changes coexist. Your surgeon will assess breast width, skin quality, symmetry and expectations before recommending an approach. Implants may be placed behind breast tissue or muscle depending on anatomy; incision location varies. Realistic expectations matter because implants are not lifetime devices and results change with aging, weight and gravity.

After mastectomy, reconstruction may use an implant or your own tissue. The exact option depends on whether radiotherapy was needed, the size and shape of the other breast, what tissue is available, and practical factors such as recovery time and time off work. Reconstruction can improve quality of life and body image after breast cancer. If breast cancer is found in a previously augmented breast, skin-sparing mastectomy with immediate expander or implant reconstruction can be offered safely, with a similar safety profile to patients without prior augmentation. An implant likely does not delay diagnosis, lead to a more advanced stage, or reduce survival.

Implant rupture can occur without symptoms and may be found during examination or imaging. Complications such as rupture can lead to replacement surgery, with possible additional costs, suboptimal results and repeated adverse events. A ruptured breast implant should be replaced, and this recommendation applies to any implant type. In replacement or reconstruction settings, silicone gel implants may be used where saline is required for first-time augmentation. After mastectomy, surgeons may replace both implants and assess soft-tissue adequacy before upsizing. Your surgeon should explain the conditions for new implants. Replacement decisions also depend on implant position, tissue quality and your expectations. Replacement may involve removing old implant material and assessing capsule and tissue quality.

Previous surgery can change tissue quality, scar position or implant pocket, so planning should be individual. Secondary augmentation-mastopexy can be performed safely with good aesthetic outcomes in appropriately selected patients who have undergone previous breast surgery with or without implants. Tissue-related complications are more common than implant-related complications, and complication and revision rates are relatively low, with results similar to primary augmentation-mastopexy. Reoperation rates of 13–21% at three years and 20–26% at five years show breast augmentation is often a maintenance procedure. You should be informed before surgery about the possible need for additional surgery. The decision is personal, and you should weigh potential benefits with risks and complications. Scars and implant position may affect planning.

Large studies and meta-analyses found no significantly increased risk of specific connective-tissue diseases among women with silicone breast implants. The American Society of Plastic Surgeons said there is no reason to discourage women from considering augmentation because of this risk. However, a theoretical risk may exist, especially if you already have a connective-tissue disorder, idiopathic Raynaud's phenomenon, or an affected first-degree relative. Removing implants has not been shown to alter existing disease or prevent new disease. The ASPS consensus also noted insufficient information to determine whether silicone in implant form can be implicated as a cause of scleroderma-like disorders or other autoimmune disease; if any causal association existed, the statistical risk would likely be very low.

Breast augmentation involves creating a pocket for an implant, so bleeding control matters. Sources note that blood coagulation tests should be checked and verified, medicines that interfere with clotting avoided, and blood pressure monitored before, during and after surgery. Careful haemostasis and correct tissue planes help reduce bleeding, and a drain may be used if needed. Hypocoagulation is listed among possible causes of early postoperative hematoma. In one reported case series, hematomas occurred in about 1% of augmentation mammaplasties. Bleeding and infection are described as rare early complications, and implant-related problems are generally aesthetic rather than health-threatening. A complete history and physical examination are part of assessment.

After major weight loss, breasts may show severe drooping, asymmetry, upper-pole emptiness and poor skin elasticity. Assessment should confirm weight stability, medical conditions, goals, expectations and up-to-date breast imaging if needed. If volume is significantly reduced, the surgeon assesses whether enough tissue exists for autologous augmentation; if not, augmentation with a lift may be considered. Good skin tone may allow augmentation alone, while excess skin or a loose fold may need combined or staged surgery. Fat transfer needs stable weight and donor fat and may require more than one procedure. The surgeon also discusses limitations and realistic expectations. Weight stability matters because further loss can change breast size, shape and long-term outcomes.

Age alone does not rule out surgery. The key points are correct indications, suitable health and adequately elastic skin; puberty should have ended and breast volume should have been stable for at least two years. After implant placement, procedures are not restricted by age or implant duration, and acceptable breast shape can still be achieved, sometimes with mastopexy. Breast augmentation increases size and shape but does not correct severely drooping breasts, so a lift may be needed at the same time or separately. Implants may be placed behind breast tissue, muscle or fascia, with incision choice depending on breast characteristics and surgeon-patient preference.

There is no age restriction per se, but ideally breast size should be stable for at least one year after initial development, with eighteen years as an appropriate lower age limit. Emotional maturity and realistic expectations also matter. When performed by a qualified plastic surgeon, augmentation is considered safe and effective, yet it remains major surgery with potential risks and no guaranteed result. It is also a maintenance procedure, with reoperation rates of 13–21% at three years and 20–26% at five years. Implants may be saline or silicone gel; placement, size and pocket are individualized during consultation. Older women should be carefully counselled for comorbidities that may increase complication rates, and age-related expectations should be discussed.